254 related articles for article (PubMed ID: 37513358)
21. Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids.
Grigoropoulou S; Manou D; Antoniou AI; Tsirogianni A; Siciliano C; Theocharis AD; Athanassopoulos CM
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684559
[TBL] [Abstract][Full Text] [Related]
22. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
23. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.
Wang M; Xu S; Wu C; Liu X; Tao H; Huang Y; Liu Y; Zheng P; Zhu W
Bioorg Med Chem Lett; 2016 Nov; 26(22):5450-5454. PubMed ID: 27777009
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of chalcone analogues containing a 4-oxoquinazolin-2-yl group as potential anti-tumor agents.
Han X; Peng B; Xiao BB; Sheng-Li Cao ; Yang CR; Wang WZ; Wang FC; Li HY; Yuan XL; Shi R; Liao J; Wang H; Li J; Xu X
Eur J Med Chem; 2019 Jan; 162():586-601. PubMed ID: 30472605
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
[TBL] [Abstract][Full Text] [Related]
29.
Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies.
Joshi A; Bhojwani H; Wagal O; Begwani K; Joshi U; Sathaye S; Kanchan D
Anticancer Agents Med Chem; 2022; 22(2):328-343. PubMed ID: 33858315
[TBL] [Abstract][Full Text] [Related]
32. Methoxychalcones: Effect of Methoxyl Group on the Antifungal, Antibacterial and Antiproliferative Activities.
Marques BC; Santos MB; Anselmo DB; Monteiro DA; Gomes E; Saiki MFC; Rahal P; Rosalen PL; Sardi JCO; Regasini LO
Med Chem; 2020; 16(7):881-891. PubMed ID: 31339075
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
34. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro cytotoxicity evaluation and mechanism of 5' monosubstituted chalcone derivatives as antitumor agents.
Xu X; Wang J; Yan B; Leng Y; Chen Z; Pan G; Xiang C; Teng Y
Bioorg Med Chem Lett; 2023 Apr; 85():129239. PubMed ID: 36924947
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Gallic and Cinnamic Acids Chimeric Derivatives as Anticancer Agents over HeLa Cell Line: An in silico and in vitro Study.
Nolasco-Quintana NY; González-Maya L; Razo-Hernández RS; Alvarez L
Mol Inform; 2023 Jan; 42(1):e2200016. PubMed ID: 36065495
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents.
Lu CF; Wang SH; Pang XJ; Zhu T; Li HL; Li QR; Li QY; Gu YF; Mu ZY; Jin MJ; Li YR; Hu YY; Zhang YB; Song J; Zhang SY
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]